digital therapeutics

Pharma

Eisai, Carvykti, Ozempic biosimilar—Fierce Pharma Asia

An injectable version of Leqembi faces an FDA delay. Novartis scored an expanded deal to manufacture Carvykti. An Ozempic biosim seeks a nod in China.

Angus Liu Apr 5, 2024 8:25am

Gene therapy costs, IRA model updates top ICER head's agenda

Feb 7, 2023 1:44pm